Mainz Biomed (MYNZ) Shares Outstanding (Weighted Average) (2020 - 2025)
Historic Shares Outstanding (Weighted Average) for Mainz Biomed (MYNZ) over the last 6 years, with Q2 2025 value amounting to $3.1 million.
- Mainz Biomed's Shares Outstanding (Weighted Average) rose 46275.68% to $3.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.1 million, marking a year-over-year increase of 46275.68%. This contributed to the annual value of $968234.0 for FY2024, which is 13844.72% up from last year.
- According to the latest figures from Q2 2025, Mainz Biomed's Shares Outstanding (Weighted Average) is $3.1 million, which was up 46275.68% from $968234.0 recorded in Q4 2024.
- Over the past 5 years, Mainz Biomed's Shares Outstanding (Weighted Average) peaked at $16.0 million during Q3 2023, and registered a low of $353937.0 during Q4 2022.
- Over the past 5 years, Mainz Biomed's median Shares Outstanding (Weighted Average) value was $7.2 million (recorded in 2021), while the average stood at $7.8 million.
- As far as peak fluctuations go, Mainz Biomed's Shares Outstanding (Weighted Average) tumbled by 9622.55% in 2024, and later surged by 46275.68% in 2025.
- Mainz Biomed's Shares Outstanding (Weighted Average) (Quarter) stood at $7.2 million in 2021, then crashed by 95.09% to $353937.0 in 2022, then increased by 14.73% to $406058.0 in 2023, then skyrocketed by 138.45% to $968234.0 in 2024, then surged by 224.76% to $3.1 million in 2025.
- Its Shares Outstanding (Weighted Average) stands at $3.1 million for Q2 2025, versus $968234.0 for Q4 2024 and $558751.0 for Q2 2024.